Dong Xu

Company: OBI Pharma Inc.

Job title: Senior Vice President, Head of Biostatistics and Data Management

Seminars:

Pushing the Envelope: Developing Bi-Specific ADCs Using a Novel GlycOBI™ Platform 4:30 pm

Reviewing the advantages of Dual Targeting: Enhancing efficacy by targeting multiple tumor proteins simultaneously, combats resistance with varied mechanisms of action, and broadens the target patient populations Considering the benefits and Target Selection: Selecting the optimal targets and ideal formats remains complex, requiring precise identification of tumor-specific proteins for effective dual targeting An overview of…Read more

day: Day Two